Physician

Kevin M Tomera, M.D.

According to 2025 Medicare claims, Kevin Tomera, M.D. (NPI: 1255385258) practices urology in the Janesville-Beloit, WI market, with the plurality of this provider's patient population coming from Rock, WI. This provider's primary affiliated billing organization is BELOIT HEALTH SYSTEM INC (NPI: 1679616361; TIN: 391028081) and primary practice location at 53511-1842. Tomera is affiliated with the CareMax Accountable Care Network, LLC (ACO ID: A5080), participating under the MSSP model.

Tomera's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 493 traditional Medicare patients, billed 1,834 HCPCS/CPT codes, and received $135,106 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,489 prescription claims across 425 beneficiaries totaling $67,953 in drug costs, led by Myrbetriq (Mirabegron). 2023 DME data shows 29 claims. Open Payments data shows 6 records totaling $313. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $68,238 and ending at $67,953. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $2,948 to $1,843.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	353	2,721	$115,533
2016	423	3,389	$114,065
2017	436	2,702	$95,945
2018	346	1,327	$107,968
2019	430	1,467	$112,248
2020	395	1,177	$92,016
2021	349	1,113	$90,707
2022	377	1,323	$106,252
2023	436	1,707	$125,983
2024	493	1,834	$135,106

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	148	618	$68,238
2016	191	700	$86,493
2017	208	723	$81,651
2018	189	548	$44,852
2019	231	695	$59,586
2020	232	834	$72,508
2021	261	998	$71,857
2022	318	1,162	$73,779
2023	364	1,295	$67,795
2024	425	1,489	$67,953

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	36	60	$8,594
2016	41	241	$6,843
2017	N/R	104	$24,490
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	11	$9,257
2021	N/R	12	$5,812
2022	N/R	178	$5,789
2023	N/R	29	$2,872
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	76	76	$84
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	213	413	$65
52000	Diagnostic exam of bladder and urethra using an endoscope	84	100	$54
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	47	47	$46
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	289	604	$43

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	47	2,146	$33,098
Oxybutynin Chloride Er	Oxybutynin Chloride	195	12,820	$5,248
Tamsulosin Hcl	Tamsulosin Hcl	314	22,870	$4,030
Finasteride	Finasteride	264	21,289	$2,924
Silodosin	Silodosin	39	2,358	$2,734

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$313	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kevin M. Tomera, M.D.?

Tedicare shows public-source Medicare data for Kevin M. Tomera, M.D. (NPI 1255385258), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kevin M. Tomera, M.D. have ACO affiliation data?

Kevin M. Tomera, M.D. is shown with ACO affiliation data for CareMax Accountable Care Network, LLC (MSSP, ACO ID A5080).

What billing organization is linked to Kevin M. Tomera, M.D.?

Kevin M. Tomera, M.D. is linked to BELOIT HEALTH SYSTEM INC (billing NPI 1679616361) in the available physician profile data.

Does Kevin M. Tomera, M.D. have Open Payments data?

Kevin M. Tomera, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.